Your Daily Pharma Scoop: Cellectar Bio Shows Encouraging Early Data; Arena's Ralinepag Posts Strong PAH Results [Seeking Alpha]
Bausch Health Companies Inc. (BHC)
Last bausch health companies inc. earnings: 2/19 06:59 am
Check Earnings Report
Company Research
Source: Seeking Alpha
Summary Welcome to the Daily Pharma Scoop, a daily feature from the creators of the Total Pharma Tracker, a popular biopharma Marketplace service here on Seeking Alpha. In the daily scoop, we focus in on one key investment concept from the biopharma space, and also provide quick commentary on other important news, and a set of selected links to major news from the day before. Cellectar Bio CLR 131 shows positive action in early-stage multiple myeloma study Cellectar Bio ( CLRB ) is an oncology-focused clinical stage company developing drugs based on its PDC (Phospholipid Drug Conjugates) platform. This platform enables specificity of drugs, ease of entry into the tumor microenvironment ( TME ), and controlled release of the drug payload. In an announcement yesterday, the company said that its CLR 131 product, developed using the PDC technology, achieved remarkably significant results in a phase 1b trial in relapsed/refractory multiple myeloma. Interim data from this
Show less
Read more
Impact Snapshot
Event Time:
BHC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHC alerts
High impacting Bausch Health Companies Inc. news events
Weekly update
A roundup of the hottest topics
BHC
News
- Bausch Health sets 2025 outlook at the higher end of the prior range [Seeking Alpha]Seeking Alpha
- Bausch Health Cos (NYSE:BHC) was given a new $8.00 price target on by analysts at Truist Financial Corporation.MarketBeat
- Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare ConferencePR Newswire
- 2 Strong Mid-Cap Growth Stocks Dan Loeb Bought in Q3 [Yahoo! Finance]Yahoo! Finance
BHC
Earnings
- 10/29/25 - Miss
BHC
Sec Filings
- 1/13/26 - Form 8-K
- 1/2/26 - Form 8-K
- 1/2/26 - Form 4
- BHC's page on the SEC website